Vifor Pharma AG Dividend yield

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   CHF per share 
 Price  178.65
 Dividend  2.00
 Earnings  2.78
 Cash-flow  0.00
 Book value  47.01
 Equity  40.29

Vifor Pharma AG is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Vifor Pharma AG is a company from Switzerland, and his stocks are publicly traded.

Vifor Pharma AG paid a total dividend of 130 million CHF last year, for a market value of 11,612 millions (Market Cap 7,918 millions). Dividend per share of Vifor Pharma AG is 2.00 CHF, and his stock market price 178.65 CHF.

According to the chart below, where dividend yield is displayed, Vifor Pharma AG has a dividend yield of 1.12%, lower than the amount offered by both the market average and companies from Switzerland. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare Vifor Pharma AG dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Switzerland.

Dividend yield of Vifor Pharma AG

Vifor Pharma AG Dividend Payout

About the ability of Vifor Pharma AG to maintain his current dividend of CHF 2.00 per share, an amount that accounts for 1.12%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Vifor Pharma AG payout on ernings is currently 71.94%, which is higher than the market average, and companies of Health Care industry, which are 38.54% and 25.72% respectively. Both figures show that Vifor Pharma AG can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Vifor Pharma AG is CHF 0.00 per share, which is lower than the dividend per share paid by the company of CHF 2.00, so the company does not generate enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Vifor Pharma AG, compared againt world market average, Switzerland companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies. You might also need to check full financial report of Vifor Pharma AG.

Vifor Pharma AG payout

Vifor Pharma AG Stock performance

Finally, last moth Vifor Pharma AG showed a return of -4.80% compared to a worldwide -0.46% average, and a 3.00% of Health Care firms. Over the last year, the company obtained a 84.40% versus a worldwide performance of a 5.96%. More detailed information can be seen in the following graph for Switzerland and Pharmaceuticals and Biotechnology firms.

Vifor Pharma AG stock and market return

Next companies

Vinci. France. Industrials.

Vipshop Holdings. China. Consumer Services.

Visa. USA. Financials.

Vivendi. France. Consumer Services.

VMware Inc.. USA. Technology.

Vocus Communications. Australia. Telecommunications.

Previous companies

Vienna Insurance Gro. Austria. Financials.

Vicinity Centers. Australia. Financials.

Viacom (New) Class B. USA. Consumer Services.

Via Varejo SA. Brazil. Consumer Services.

Via Varejo SA. Brazil. Consumer Services.

VF Corp. USA. Consumer Goods.



All rights reserved

 information advertisement legal

Dividends Ranking | Firm Report | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.